Metabasis

The CVRs will entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by Ligand from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events.

unknown title 2009

Please specify to the operator "Metabasis" when asked for a passcode.

BioSpace.com Featured News and Stories 2008

¶  [Sidenote: Metabasis.] _Transicio_, transiciõ is, wherby briefly we monyshe what hath ben spoken, & what may folowe, as: What he hath ben to hys contrey I haue told, now ye shal hear how he hath shewed him self to hys parẽtes.

A Treatise of Schemes and Tropes Richard Sherry

Less than a year ago, we brought into Ligand a basket of assets through our acquisition of Metabasis, and now this deal validates our ability to leverage our acquisitions and business platform to generate new deals and upside, said John L. Higgins, President and

Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals - Yahoo! Finance 2011

The General CVRs entitle holders to potential future cash payments with the sale or partnering of specified Metabasis programs, among other triggering events.

Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals - Yahoo! Finance 2011

Rights CVR that were issued at the time of Ligand's acquisition of Metabasis are expected to receive cash payments at or shortly after July 1, 2011, pursuant to the terms of the General

Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals - Yahoo! Finance 2011

Prior to Metabasis, Mr. Nguyen was a Vice President in the healthcare investment banking groups at Citi Global Markets, Inc. and Lehman Brothers, Inc. where he successfully executed numerous capital raising and strategic transactions for life science clients.

The Earth Times Online Newspaper 2010

Metabasis Therapeutics presents pre-clinical data on CS 917 and MB07811 at the American Diabetes Association meeting.

WN.com - Articles related to New targets to prevent diabetic eye disease identified 2009

In addition, Metabasis stockholders will receive for each Metabasis share four tradable Contingent Value Rights ( "CVRs") that will be registered on a Form S-4 registration statement to be filed by Ligand with the Securities and Exchange Commission.

unknown title 2009

At this time, Metabasis estimates the net cash that will be available for distribution to stockholders of Metabasis at closing will be approximately $1.8 million.

unknown title 2009